Emerging mass spectrometry technologies integrating ion mobility, TIMS–PASEF, and real-time search are enhancing sensitivity, ...
Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease which affects 3 million people worldwide.
Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni™ mass spectrometer to enable disease researchers to move beyond ...
News Medical on MSN
Bruker advances Functional Proteomics 2.0 with timsOmni™ mass spectrometry proteoform analysis for deeper insights into disease biology
Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni ™ mass spectrometer to enable disease researchers to move beyond canonical protein ...
Can you describe how the untargeted ultrahigh-performance liquid chromatography–high resolution tandem mass spectrometry (UHPLC–HRMS/MS) workflow was designed to capture both known salicylates and ...
As the biochemical basis of asthma is not yet fully understood, researchers from The Catholic University of Korea, the Korea University College of Medicine, and Seoul National University (all in Seoul ...
Scientists have developed a new way to help understand what happens in the body when people consume a plant product and the ...
Researchers have developed a diagnostic panel that identifies cognitive decline by analyzing how blood proteins fold. This ...
Researchers at the MPI of Biochemistry and TUM have examined the cerebrospinal fluid of 5,000 patients with neurological diseases and discovered new ...
A team of scientists from the University of Manchester and Oxford have synthesized stable nitrogen chain radical anions under ambient conditions. These molecules, which are normally too reactive to ...
The UPLC system was configured with an Acquity Premier Oligonucleotide C18 column (1.7 µm, 2.1 × 50 mm). The aqueous and ...
Background/aims Posterior capsule opacification (PCO) is the most frequent long-term complication after cataract surgery, caused by proliferation of residual lens epithelial cells (LECs). Metformin, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results